Covington Capital Management
- SEC CIK
- 0001323119
- Latest filing
- Nov 15, 2022
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by Covington Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q3 2022 holdings
- Shares (Q3 2022)
- 247,500
- Value
- $9.79M
- % of portfolio
- 0.4%
- Quarters held
- 2
- Since Q2 2022